Michael Hansen currently serves as the Corporate Business Development Director for North America at Eppendorf Group, where he plays a pivotal role in shaping the company's strategic direction in the life sciences sector. With a robust background in licensing, strategy, and business development, Michael is...
Michael Hansen currently serves as the Corporate Business Development Director for North America at Eppendorf Group, where he plays a pivotal role in shaping the company's strategic direction in the life sciences sector. With a robust background in licensing, strategy, and business development, Michael is adept at identifying and evaluating lucrative investment and partnership opportunities across the U.S. and Canada. His leadership is particularly instrumental in the Eppendorf Innovation Company (EpIC), a newly established department that acts as a vital bridge between Eppendorf and innovative startups, as well as cutting-edge technology centers.
In his role, Michael is responsible for conducting comprehensive business case analyses and technology evaluations, ensuring that Eppendorf remains at the forefront of advancements in medical diagnostics and genetics. His expertise in deal negotiations and financial analysis enables him to forge strategic alliances that facilitate the commercialization of high-impact technologies, from initial discovery through to market launch. Michael’s proven track record in navigating the complexities of clinical trials and regulatory landscapes, including FDA compliance and patent considerations, positions him as a key player in driving Eppendorf’s growth in a competitive market.
Michael’s commitment to relationship building is evident in his collaborative approach, fostering partnerships that not only enhance Eppendorf's product offerings but also contribute to the broader life sciences community. By leveraging his skills in strategy and commercialization, he is dedicated to propelling innovative solutions that address critical challenges in healthcare, particularly in the realms of cancer research and diagnostics. As he continues to lead initiatives that align with Eppendorf's mission, Michael Hansen exemplifies the dynamic leadership necessary to thrive in today’s rapidly evolving life sciences landscape.
